Skip to main content
Home

Top menu InfoLep

  • About InfoLep

Main navigation

  • Home
  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day 2022
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Antimicrobial resistance in leprosy
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
  • Publications
  • Organizations

Top menu - mobile infoLep

  • About InfoLep

Search

Refine your results

Refine your results


Selected filters

  • Reset filters
  • Erythema nodosum leprosum - enl (Type 2 reaction)

Filter by type

  • Publications only

NTD

  • Leprosy (Hansen disease) (11)

Subject

  • (-) Erythema nodosum leprosum - enl (Type 2 reaction) (11)
  • Complications and reactions (8)
  • Treatment (1)

Publication Type

  • Article (10)
  • Dissertation / Thesis (1)
  • Full text online (8)
  • Systematic review (1)

Journal

  • Frontiers in immunology (2)
  • Frontiers in medicine (1)
  • Journal of immunology (Baltimore, Md. : 1950) (1)
  • Open Forum Infectious Diseases (1)
  • PLoS neglected tropical diseases (2)
  • The American journal of tropical medicine and hygiene (1)
  • The Journal of Immunology (1)
  • The Journal of infectious diseases (1)

Year of Publication

  • 2021 (2)
  • 2020 (1)
  • 2019 (2)
  • 2017 (3)
  • 2016 (2)
  • 2005 (1)

Language

  • English (11)

Regional focus

  • African Region (AFR) (3)
    • Ethiopia (3)
  • Region of the Americas (AMR) (1)
    • Brazil (1)
  • South-East Asia Region (SEAR) (1)
    • India (1)
 
  • Relevance
  • Date
11 items

Publication

Mycobacterium leprae Induces Neutrophilic Degranulation and Low-Density Neutrophil Generation During Erythema Nodosum Leprosum.

Tavares I, Dos Santos JB, Pacheco FDS, et al. Frontiers in medicine. 2021;
Download PDF

Publication

Low density neutrophils as a potential biomarker of leprosy severity

Tavares I, Dos Santos JB, Pacheco FDS, et al. The Journal of Immunology. 2020;

Publication

Changes in B Cell Pool of Patients With Multibacillary Leprosy: Diminished Memory B Cell and Enhanced Mature B in Peripheral Blood.

Nogueira O, Gandini M, Cabral N, et al. Frontiers in immunology. 2021;
Download PDF

Publication

Involvement of TNF-Producing CD8 Effector Memory T Cells with Immunopathogenesis of Erythema Nodosum Leprosum in Leprosy Patients.

Silva PH, Santos L, Mendes M, et al. The American journal of tropical medicine and hygiene. 2019;

Publication

DNA Sensing via TLR-9 Constitutes a Major Innate Immunity Pathway Activated during Erythema Nodosum Leprosum.

Dias AA, Silva CO, Santos JP, et al. Journal of immunology (Baltimore, Md. : 1950). 2016;

Publication

Increased activated memory B-cells in the peripheral blood of patients with erythema nodosum leprosum reactions.

Negera E, Walker SL, Bekele Y, et al. PLoS neglected tropical diseases. 2017; 11 (12) : e0006121.
Download PDF

Publication

1345. randomized control trial to evaluate the clinical and cytokine response profile to oral Thalidomide in leprosy patients with erythema nodosum leprosum

Chopra A, Mitra D. Open Forum Infectious Diseases. 2019;
Download PDF

Publication

New Insight into the Pathogenesis of Erythema Nodosum Leprosum: The Role of Activated Memory T-Cells.

Negera E, Bobosha K, Walker SL, et al. Frontiers in immunology. 2017;
Download PDF

Publication

T-cell regulation in Erythema Nodosum Leprosum.

Negera E, Walker S, Bobosha K, et al. PLoS neglected tropical diseases. 2017; 11 (10) : e0006001.
Download PDF

Publication

The immunopathology of erythema nodosum leprosum

Gobena E. London School of Hygiene & Tropical Medicine. 2016;
Download PDF

Publication

Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation.

Haslett P, Roche P, Butlin RC, et al. The Journal of infectious diseases. 2005; 192 (12) : 2045-53.
Download PDF

Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications
  • Organizations

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2022 InfoNTD